OrbiMed’s electroCore ECOR Stock Holding History

OrbiMed’s Portfolio ECOR Stock Details ECOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-26,548	Closed	-$2.49M	–	133
2018 Q4	$2.49M	Hold	26,548	–	–	0.05%	115
2018 Q3	$5.57M	Hold	26,548	–	–	0.07%	127
2018 Q2	$6.57M	Buy	+26,548	New	+$7.21M	0.08%	124

Other funds holding ECOR

HCM

Hodges Capital Management Dallas, Texas $1.21B AUM 49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OrbiMed's ECOR Position: Q1 2019 in Review

OrbiMed sold out of electroCore (ECOR) in Q1 2019, closing a stake of 26,548 shares — an estimated $2.49M sold.

OrbiMed first reported a position in ECOR in Q2 2018 and held it in 3 quarters. The position peaked at $6.57M in Q2 2018. 41 funds tracked by Wall St. Rank hold ECOR as of Q1 2019.

OrbiMed reported no remaining electroCore position as of Q1 2019 after selling out during the quarter.
OrbiMed sold 26,548 electroCore shares in Q1 2019, an estimated $2.49M.
OrbiMed first reported a position in electroCore in Q2 2018 and held it in 3 quarters.
OrbiMed's electroCore position peaked at $6.57M in Q2 2018.
41 funds tracked by Wall St. Rank held electroCore as of Q1 2019.

Based on OrbiMed's 13F filing for Q1 2019, filed 15 May 2019.